regulation
16 stories tagged "regulation"
Mice Trained to Spot THC Gave the THC Answer for CBN, the Sleep-Gummy Cannabinoid
Mice given CBN twice daily for five days grew tolerant and twitched once a receptor blocker cut it off. A Canopy Growth sleep trial of CBN found about 0.5 fewer awakenings a night and missed its main measure.
InvestigationsOven Gloves Bought From a Top Online Retailer Tested 89 Percent Asbestos
A private citizen asked two Italian mineralogists whether a cheap pair of heat-resistant gloves labeled Made in China was asbestos. The lab answered 89 percent chrysotile by weight, and the listing never said so.
InvestigationsWomen Who Cleaned Lost Lung Function at a Pace Compared to Smoking 10 to 20 Cigarettes a Day
Over 20 years, women who cleaned at home or for a living lost lung function faster than women who didn't. Tested scented products gave off carcinogens their labels never named, and single-chemical safety limits weren't built for the mixture under your sink.
Drugs & FDAVaping Beat the Patch in the Strongest Evidence Yet. The WHO Told Governments Not to Allow It.
Eighty randomized trials and nearly 30,000 people put nicotine vapes ahead of patches and gum, with high-certainty evidence. More than half of adults believe vaping is as dangerous as smoking. The agencies that warned them never had the trial data on their side.
Drugs & FDATwenty-Six Days After Altria Sued, the FDA Said It May Scrap Its Vape Rulebook
Out of 26.6 million nicotine-product applications since 2020, the FDA authorized 75. Now, with a tobacco giant's lawsuit named in its own notice, the agency says it may replace the whole framework.
Drugs & FDAKennedy's Peptide Plan Reaches the White House, and Wall Street Is Already Counting the Money
Peptides already sell on a Queens bodega shelf, so moving them into licensed pharmacies is progress. Whether it protects anyone depends on one missing rule: test each lot and report every injury.
Drugs & FDAFDA's Anktiva Approval for Papillary-Only Bladder Cancer Cites No Papillary-Only Patients
Seventeen months after refusing even to review ImmunityBio's application, the FDA expanded Anktiva's label by extrapolating from carcinoma in situ, and its announcement never mentioned the 80 papillary-only patients the company had actually studied.
Drugs & FDAFour Years After Congress Dropped the Animal-Testing Requirement for New Drugs, the FDA Finally Updated Its Rulebook to Match
The FDA's direct final rule swaps 'animal studies' for 'nonclinical studies' across its regulations. It eliminates no animal testing, moves no evidentiary bar, and sets up no program to prove the alternatives it now invites actually work.
InvestigationsAn 'A' for the Air Outside, Nearly Three Times Dirtier Inside
The EPA rated one Virginia region's outdoor air a clean 'A.' Inside the public-housing apartments of elderly and disabled residents, fine-particle pollution ran nearly three times higher, the air most long-term pollution studies miss.
Drugs & FDAThe FDA Is Building an On-Ramp for Medical AI That Can Hallucinate
The FDA has cleared more than 1,000 AI medical devices and not one large language model. Its new discussion paper starts building the pathway for the ones that can make things up, with faster delivery to market named as an agency priority.
Nutrition & FoodNo One Guards the Toddler Food Aisle: 81 Percent of Its Foods Are Ultra-Processed
Parents assume the baby aisle is vetted. It isn't. No US rule makes toddler food meet a nutrient standard, and an Austin audit of 2,783 products marketed for 6-to-36-month-olds found 81 percent ultra-processed and nearly half failing a WHO benchmark.
Drugs & FDAFor Years, a Foreign Factory Could Put the Active Ingredient in Your Medicine and Never Tell the FDA
The FDA led with a paperwork convenience for manufacturers. Buried underneath was the admission that it can't always trace where a drug's active ingredient was made, a blind spot Congress had to order it to close.
Drugs & FDAThe FDA's Fix for a $10 Billion Flood of Chinese Vapes Is a Form the Smugglers Will Ignore
Foreign manufacturers ship most of America's vapes and falsify the customs forms to do it. Washington's answer is to ask them to register with the agency they already evade.
Nutrition & FoodThe thin trial behind England's next supermarket-layout mandate
A non-randomized trial of 36 English discount stores produced a moment-of-implementation bump in produce sales that lost statistical significance by three months, and a household-purchasing signal that never landed. The authors' immediate call for a national layout mandate is the louder finding.
Drugs & FDAAndrew Huberman's peptide masterclass and the published evidence
Andrew Huberman's June 1 episode on peptides walks through BPC-157 and seven other compounds. The published human evidence for its lead substance runs to fewer than thirty people.
InvestigationsVietnam's New Integrity Rule Arrives 251 Retractions Late
Vietnam's Ministry of Science and Technology issued a research-integrity framework with permanent bans on May 25, 2026. The Retraction Watch database already lists 251 retractions carrying Vietnamese affiliations.